USD 1.0
(2.3%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 981 Thousand USD | -0.3% |
2022 | 984 Thousand USD | -16.4% |
2021 | 1.17 Million USD | 247.2% |
2020 | 339 Thousand USD | -24.16% |
2019 | 447 Thousand USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | -100.0% |
2015 | 7.79 Million USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | 0.0% |
2009 | - USD | 0.0% |
2008 | - USD | 0.0% |
2007 | - USD | 0.0% |
2006 | - USD | 0.0% |
2005 | - USD | 0.0% |
2004 | - USD | 0.0% |
2003 | - USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 654 Thousand USD | -8.02% |
2024 Q1 | 711 Thousand USD | -27.52% |
2023 Q2 | 874 Thousand USD | -6.02% |
2023 Q4 | 981 Thousand USD | 19.63% |
2023 Q3 | 820 Thousand USD | -6.18% |
2023 FY | 981 Thousand USD | -0.3% |
2023 Q1 | 930 Thousand USD | -5.49% |
2022 FY | 984 Thousand USD | -16.4% |
2022 Q4 | 984 Thousand USD | -5.02% |
2022 Q2 | 1.08 Million USD | -4.23% |
2022 Q1 | 1.13 Million USD | -3.48% |
2022 Q3 | 1.03 Million USD | -4.78% |
2021 Q2 | 226 Thousand USD | -20.42% |
2021 Q1 | 284 Thousand USD | -16.22% |
2021 FY | 1.17 Million USD | 247.2% |
2021 Q4 | 1.17 Million USD | 600.6% |
2021 Q3 | 168 Thousand USD | -25.66% |
2020 Q4 | 339 Thousand USD | -13.74% |
2020 Q1 | 403 Thousand USD | -9.84% |
2020 FY | 339 Thousand USD | -24.16% |
2020 Q2 | 419 Thousand USD | 3.97% |
2020 Q3 | 393 Thousand USD | -6.21% |
2019 Q2 | 533 Thousand USD | -7.14% |
2019 Q3 | 490 Thousand USD | -8.07% |
2019 Q4 | 447 Thousand USD | -8.78% |
2019 FY | 447 Thousand USD | 0.0% |
2019 Q1 | 574 Thousand USD | 0.0% |
2018 FY | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 FY | - USD | -100.0% |
2016 Q2 | 5.9 Million USD | -13.2% |
2016 Q1 | 6.8 Million USD | -12.8% |
2016 Q3 | - USD | -100.0% |
2015 Q4 | 7.79 Million USD | 0.67% |
2015 FY | 7.79 Million USD | 0.0% |
2015 Q2 | 7.69 Million USD | 33.89% |
2015 Q3 | 7.74 Million USD | 0.66% |
2015 Q1 | 5.74 Million USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2011 Q2 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2010 FY | - USD | 0.0% |
2010 Q4 | - USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2009 Q4 | - USD | 0.0% |
2009 FY | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2008 Q4 | - USD | 0.0% |
2008 FY | - USD | 0.0% |
2007 FY | - USD | 0.0% |
2007 Q2 | - USD | 0.0% |
2007 Q4 | - USD | 0.0% |
2006 Q4 | - USD | 0.0% |
2006 Q2 | - USD | 0.0% |
2006 FY | - USD | 0.0% |
2005 FY | - USD | 0.0% |
2005 Q4 | - USD | 0.0% |
2005 Q2 | - USD | 0.0% |
2004 FY | - USD | 0.0% |
2004 Q4 | - USD | 0.0% |
2004 Q2 | - USD | 0.0% |
2003 FY | - USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Alphatec Holdings, Inc. | 541.67 Million USD | 99.819% |
Nemaura Medical Inc. | 20.03 Million USD | 95.102% |
NeuroPace, Inc. | 72.39 Million USD | 98.645% |
LENSAR, Inc. | 2.3 Million USD | 57.514% |
Rapid Micro Biosystems, Inc. | 7.34 Million USD | 86.646% |
TriSalus Life Sciences, Inc. | 1.59 Million USD | 38.495% |
Apyx Medical Corporation | 38.5 Million USD | 97.452% |
Cutera, Inc. | 431.91 Million USD | 99.773% |
STRATA Skin Sciences, Inc. | 15.63 Million USD | 93.725% |
BioSig Technologies, Inc. | 452 Thousand USD | -117.035% |
Accelerate Diagnostics, Inc. | 39.22 Million USD | 97.499% |
Integra LifeSciences Holdings Corporation | 1.68 Billion USD | 99.942% |
Axonics, Inc. | 27.61 Million USD | 96.448% |
IRIDEX Corporation | 2.74 Million USD | 64.275% |
PROCEPT BioRobotics Corporation | 79.2 Million USD | 98.761% |
TELA Bio, Inc. | 42.78 Million USD | 97.707% |
Tivic Health Systems, Inc. | 369 Thousand USD | -165.854% |
RxSight, Inc. | 3.01 Million USD | 67.43% |
Align Technology, Inc. | 96.96 Million USD | 98.988% |
INVO Bioscience, Inc. | 8.68 Million USD | 88.703% |
electroCore, Inc. | 626 Thousand USD | -56.709% |
Telesis Bio, Inc. | 34.38 Million USD | 97.147% |
Viemed Healthcare, Inc. | 10.27 Million USD | 90.449% |
Quipt Home Medical Corp. | 98.94 Million USD | 99.009% |
Anika Therapeutics, Inc. | 29.03 Million USD | 96.622% |
Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | 58.22% |
Lucid Diagnostics Inc. | 15.25 Million USD | 93.569% |
Dynatronics Corporation | 6.68 Million USD | 85.332% |
Modular Medical, Inc. | 1.19 Million USD | 17.563% |
ReShape Lifesciences Inc. | 262 Thousand USD | -274.427% |
Talis Biomedical Corporation | 19.66 Million USD | 95.012% |
PetVivo Holdings, Inc. | 1.36 Million USD | 28.134% |
InMode Ltd. | 9.01 Million USD | 89.121% |
Envoy Medical, Inc. | 404 Thousand USD | -142.822% |
Bruker Corporation | 1.37 Billion USD | 99.929% |
Helius Medical Technologies, Inc. | 57 Thousand USD | -1621.053% |
DexCom, Inc. | 2.59 Billion USD | 99.962% |
Nexalin Technology, Inc. | 4463.00 USD | -21880.73% |
PAVmed Inc | 48.72 Million USD | 97.987% |
Viveve Medical, Inc. | 5.34 Million USD | 81.66% |
Cerus Corporation | 95.99 Million USD | 98.978% |
Movano Inc. | 252 Thousand USD | -289.286% |
Cytek Biosciences, Inc. | 33.17 Million USD | 97.043% |
Nexalin Technology, Inc. | 4463.00 USD | -21880.73% |
IceCure Medical Ltd | 599 Thousand USD | -63.773% |
Tandem Diabetes Care, Inc. | 415.66 Million USD | 99.764% |
enVVeno Medical Corporation | 1.4 Million USD | 30.029% |
908 Devices Inc. | 5.94 Million USD | 83.499% |
ClearPoint Neuro, Inc. | 13.94 Million USD | 92.963% |
Orthofix Medical Inc. | 134.19 Million USD | 99.269% |
Surmodics, Inc. | 29.4 Million USD | 96.664% |
Outset Medical, Inc. | 136.18 Million USD | 99.28% |
Venus Concept Inc. | 79.69 Million USD | 98.769% |
iRhythm Technologies, Inc. | 129.82 Million USD | 99.244% |
Treace Medical Concepts, Inc. | 70.3 Million USD | 98.605% |
Nano-X Imaging Ltd. | 8.39 Million USD | 88.316% |
Aethlon Medical, Inc. | 940.31 Thousand USD | -4.327% |
Inogen, Inc. | 21.92 Million USD | 95.525% |
IRadimed Corporation | 2.04 Million USD | 51.983% |
MaxCyte, Inc. | 18.74 Million USD | 94.766% |
Pulmonx Corporation | 41.42 Million USD | 97.632% |
PAVmed Inc. | 48.72 Million USD | 97.987% |
iCAD, Inc. | 461 Thousand USD | -112.798% |
OrthoPediatrics Corp. | 23.76 Million USD | 95.871% |
DIH Holding US, Inc. Warrants | 1.99 Million USD | 50.864% |
Monogram Orthopaedics, Inc. | 491.99 Thousand USD | -99.394% |
NeuroOne Medical Technologies Corporation | 184.4 Thousand USD | -431.996% |
SI-BONE, Inc. | 38.99 Million USD | 97.484% |
Semler Scientific, Inc. | 70 Thousand USD | -1301.429% |
Beyond Air, Inc. | 17.83 Million USD | 94.5% |
FONAR Corporation | 41.67 Million USD | 97.646% |
AxoGen, Inc. | 69.29 Million USD | 98.584% |
Biotricity, Inc. | 23.87 Million USD | 95.892% |
Cytosorbents Corporation | 18.31 Million USD | 94.643% |
ZimVie Inc. | 521.92 Million USD | 99.812% |
Tactile Systems Technology, Inc. | 50.37 Million USD | 98.053% |
Inari Medical, Inc. | 32.04 Million USD | 96.939% |
UFP Technologies, Inc. | 46.03 Million USD | 97.869% |
DIH Holdings US, Inc. Class A Common Stock | 1.99 Million USD | 50.864% |
QT Imaging Holdings, Inc. | 3.07 Million USD | 68.057% |
Sight Sciences, Inc. | 35.41 Million USD | 97.23% |
Insulet Corporation | 1.44 Billion USD | 99.932% |
Profound Medical Corp. | 7.9 Million USD | 87.583% |
Bioventus Inc. | 409.47 Million USD | 99.76% |
InspireMD, Inc. | 1.59 Million USD | 38.495% |
BrainsWay Ltd. | 471 Thousand USD | -108.28% |
BIOLASE, Inc. | 17.91 Million USD | 94.523% |
Heart Test Laboratories, Inc. | 1.03 Million USD | 5.34% |
Tenon Medical, Inc. | 1.17 Million USD | 16.368% |
Autonomix Medical, Inc. Common Stock | 1 Million USD | 2.096% |
CVRx, Inc. | 30.61 Million USD | 96.795% |
AdaptHealth Corp. | 2.29 Billion USD | 99.957% |
Sintx Technologies, Inc. | 4.24 Million USD | 76.89% |
Acutus Medical, Inc. | 38.47 Million USD | 97.451% |
Vivos Therapeutics, Inc. | 1.99 Million USD | 50.827% |
NanoVibronix, Inc. | 5000.00 USD | -19520.0% |
Quanterix Corporation | 41.46 Million USD | 97.634% |
LivaNova PLC | 640.4 Million USD | 99.847% |
Co-Diagnostics, Inc. | 2.99 Million USD | 67.197% |
Varex Imaging Corporation | 469.5 Million USD | 99.791% |
Vivani Medical, Inc. | 20.69 Million USD | 95.26% |
Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | 58.22% |
Sensus Healthcare, Inc. | 783 Thousand USD | -25.287% |
Pacific Biosciences of California, Inc. | 933.93 Million USD | 99.895% |
TransMedics Group, Inc. | 515.94 Million USD | 99.81% |
ReWalk Robotics Ltd. | 1.9 Million USD | 48.45% |
NeuroMetrix, Inc. | 240.87 Thousand USD | -307.263% |
Spectral AI, Inc. | 1.28 Million USD | 23.894% |
Hyperfine, Inc. | 185 Thousand USD | -430.27% |
Establishment Labs Holdings Inc. | 192.22 Million USD | 99.49% |
Biomerica, Inc. | 785 Thousand USD | -24.968% |
Bone Biologics Corporation | - USD | -Infinity% |
AVITA Medical, Inc. | 449.48 Thousand USD | -118.251% |
Bluejay Diagnostics, Inc. | 370.1 Thousand USD | -165.06% |
Silk Road Medical, Inc | 84.63 Million USD | 98.841% |